Key result
The combined NEWS2 and prehospital lactate score (NEWS2-L) strongly predicted early mortality in syncope patients, outperforming either score alone.
Why the study?
The predictive capacity of NEWS2 and prehospital lactate, individually and combined, to detect syncope patients at risk of early in-hospital mortality needed evaluation.
Does the combined NEWS2-L score improve the prediction of early mortality in adult syncope patients in the prehospital setting compared to NEWS2 or pLA alone?
Cohort (n=361)
Yes
Does the combined NEWS2-L score improve the prediction of early mortality in adult syncope patients in the prehospital setting compared to NEWS2 or pLA alone?
The NEWS2-L score, combining standard physiological parameters and prehospital lactate, accurately stratifies the risk of early mortality in prehospital syncope patients.
Answers are grounded in this paper and cite their sources.
NEWS2-L may aid prehospital syncope risk stratification; leaves open prospective validation before clinical adoption.
Syncope is defined as the nontraumatic, transient loss of awareness of rapid onset, short duration and with complete spontaneous recovery, and accounts for 1%–3% of all visits to the emergency department. The objective of this study was to evaluate the predictive capacity of the National Early Warning Score 2 (NEWS2) and prehospital lactate (pLA), individually and combined, at the prehospital level to detect patients with syncope at risk of early mortality (within 48 h) in the hospital environment. A prospective, multicenter cohort study without intervention was carried out on syncope patients aged over 18 who were given advanced life support and taken to the hospital. Our study included a total of 361 cases. Early mortality affected 21 patients (5.8%). The combined score formed by the NEWS2 and the pLA (NEWS2-L) obtained an AUC of 0.948 (95% CI: 0.88–1) and an odds ratio of 86.25 (95% CI: 11.36–645.57), which is significantly higher than that obtained by the NEWS2 or pLA in isolation (p = 0.018). The NEWS2-L can help stratify the risk in patients with syncope treated in the prehospital setting, with only the standard measurement of physiological parameters and pLA.
No takes yet. Share an insight, caveat, or question.
Martín‐Rodriguez et al. (2020) conducted a cohort in Syncope (n=361). Combined NEWS2 and prehospital lactate (NEWS2-L) vs. NEWS2 or prehospital lactate in isolation was evaluated on Early mortality (within 48 h) (OR 86.25, 95% CI 11.36-645.57, p=0.018). The combined NEWS2 and prehospital lactate score (NEWS2-L) strongly predicted early mortality in syncope patients, outperforming either score alone.
Synapse has enriched 10 related papers. Consider them for comparative context: